Yunping Bai
Collaborative Innovation Center For Chinese Medicine And Respiratory Diseases Co Constructed By Henan Province & Education Ministry Of P.R. China/Henan Key Laboratory Of Chinese Medicine For Respiratory Diseases
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Kangxianhuanji formula and its component rutin ameliorate acute exacerbation of idiopathic pulmonary fibrosis by targeting GLUT1 to suppress HIF-1α-mediated glycolysis.
Journal: Frontiers in immunology
Published: January 08, 2026
The effective-compound compatibility of JHF inhibits fibroblast activation in pulmonary fibrosis by enhancing PINK1/PARK2-mediated mitophagy.
Journal: Scientific reports
Published: November 22, 2024
Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: December 26, 2022
Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 19, 2022
Yangqing Chenfei formula attenuates silica-induced pulmonary fibrosis by suppressing activation of fibroblast via regulating PI3K/AKT, JAK/STAT, and Wnt signaling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 25, 2022
Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 01, 2021
Effective-compound combination inhibits the M2-like polarization of macrophages and attenuates the development of pulmonary fibrosis by increasing autophagy through mTOR signaling.
Journal: International immunopharmacology
Published: September 25, 2021
A pharmacological approach to study the active compounds in Jinshui Huanxian formula in treatment of pulmonary fibrosis.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: March 19, 2020
A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2.
Journal: Frontiers in pharmacology
Published: February 04, 2018
Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 18, 2017
Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.
Journal: Bioscience reports
Published: January 11, 2017
Randomized controlled multicenter clinical trial for integrated treatment of community-acquired pneumonia based on traditional Chinese medicine syndrome differentiation.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: February 23, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026